TrialPanorama/TrialPanorama-database huggingface dataset:
Study 2066454 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 28122361 — Monitoring Biomarker (MOI): HBV DNA
Study 21269484 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 21269484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 2906556 — Surrogate Endpoint (SUR): Blood pressure
Study 31023832 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31023832 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 29921320 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 27418458 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 20464812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11823754 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 23754188 — Safety Biomarker (SAF): Interleukin 1
Study 23754188 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 15882144 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 1313369 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 2865093 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 27418551 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 22795281 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 22795281 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 22795281 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22795281 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 18498916 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study 10561191 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 1890155 — Surrogate Endpoint (SUR): Blood pressure
Study 26975590 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16260696 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 16260696 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 11320544 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 11320544 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29502374 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25277614 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25277614 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 11593109 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11593109 — Surrogate Endpoint (SUR): Serum creatinine
Study 11593109 — Surrogate Endpoint (SUR): Blood pressure
Study 9533423 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9533423 — Surrogate Endpoint (SUR): Blood pressure
Study 9533423 — Surrogate Endpoint (SUR): Serum potassium
Study 2655909 — Surrogate Endpoint (SUR): Blood pressure
Study 27984412 — Surrogate Endpoint (SUR): Blood pressure
Study 26031551 — Surrogate Endpoint (SUR): Blood pressure
Study 16485516 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16485516 — Surrogate Endpoint (SUR): Blood pressure
Study 7595749 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2266673 — Surrogate Endpoint (SUR): Blood pressure
Study 17596725 — Predictive Biomarker (PRD): LCAT mRNA
Genes: LCAT
Study 23907233 — Surrogate Endpoint (SUR): Bone mineral density
Study 15562791 — Surrogate Endpoint (SUR): Bone mineral density
Study 15777290 — Surrogate Endpoint (SUR): Blood pressure
Study 30156312 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30156312 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 11350098 — Surrogate Endpoint (SUR): Blood pressure
Study 1975487 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30642296 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 24997634 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 2182032 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28514205 — Predictive Biomarker (PRD): APLNR mRNA
Genes: APLNR; AGTRL1; APJ
Study 17556414 — Surrogate Endpoint (SUR): Serum creatinine
Study 29979479 — Surrogate Endpoint (SUR): Blood pressure
Study 23983269 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 21168715 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 29777115 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study 27118441 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 27118441 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 27118441 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 27118441 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 14693626 — Surrogate Endpoint (SUR): Blood pressure
Study 11668132 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 2537562 — Surrogate Endpoint (SUR): Serum creatinine
Study 2537562 — Surrogate Endpoint (SUR): Serum potassium
Study 15651723 — Surrogate Endpoint (SUR): Blood pressure
Study 8654630 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 1846783 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 30606237 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 23903802 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study 23903802 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 23903802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23903802 — Surrogate Endpoint (SUR): Serum calcium
Study 22932160 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8776186 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 6494455 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 6494455 — Surrogate Endpoint (SUR): Serum creatinine
Study 19103995 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19103995 — Surrogate Endpoint (SUR): Blood pressure
Study 18422199 — Predictive Biomarker (PRD): TFF1 mRNA
Genes: TFF1; BCEI; PS2
Study 18422199 — Predictive Biomarker (PRD): PCLAF mRNA
Genes: PCLAF; KIAA0101; NS5ATP9; PAF; L5
Study 30540808 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 15758880 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 7555507 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1695491 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 28510680 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 19102912 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10824623 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 31466618 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 27478305 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 27478305 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 27478305 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22510305 — Surrogate Endpoint (SUR): Blood pressure
Study 20119581 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7707151 — Surrogate Endpoint (SUR): Blood pressure
Study 2885064 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 29843226 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29843226 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26687959 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 26687959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16957427 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29667099 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16915361 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 8789313 — Predictive Biomarker (PRD): Liver iron
Study 26946616 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 24784832 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24784832 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22472562 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 9523803 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 16999714 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 28530840 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 21352464 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 1097194 — Surrogate Endpoint (SUR): Blood pressure
Study 23686891 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23686891 — Surrogate Endpoint (SUR): Blood pressure
Study 18060626 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18060626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28439629 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 24919604 — Safety Biomarker (SAF): Protein AMBP
Genes: AMBP; HCP; ITIL
Study 24919604 — Surrogate Endpoint (SUR): Blood pressure
Study 15362934 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15362934 — Safety Biomarker (SAF): Interleukin 1
Study 15362934 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15362934 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 10631623 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 29985236 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 24382614 — Surrogate Endpoint (SUR): Blood pressure
Study 9655655 — Surrogate Endpoint (SUR): Blood pressure
Study 9655655 — Surrogate Endpoint (SUR): Serum creatinine
Study 11108307 — Predictive Biomarker (PRD): THPO mRNA
Genes: THPO; MGDF
Study 9512875 — Surrogate Endpoint (SUR): Blood pressure
Study 2429095 — Surrogate Endpoint (SUR): Blood pressure
Study 29718967 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 27236272 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 27236272 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 12704402 — Predictive Biomarker (PRD): TEF mRNA
Genes: TEF; KIAA1655
Study 12704402 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 9878015 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27659294 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 11822998 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 7631610 — Surrogate Endpoint (SUR): Blood pressure
Study 6182175 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 30581109 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 20146627 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 2313527 — Surrogate Endpoint (SUR): Probing pocket depth
Study 19494788 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 14742841 — Surrogate Endpoint (SUR): Bone mineral density
Study 22084374 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 16836171 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 10852763 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 29618121 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 29618121 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 29618121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25695485 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 23726668 — Predictive Biomarker (PRD): ACSS3 mRNA
Genes: ACSS3
Study 23726668 — Predictive Biomarker (PRD): CSGALNACT1 mRNA
Genes: CSGALNACT1; CHGN; GALNACT1; UNQ656/PRO1287
Study 18766387 — Surrogate Endpoint (SUR): Probing pocket depth
Study 11321874 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 11321874 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study 29409951 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 26561632 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21262507 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8342751 — Surrogate Endpoint (SUR): Blood pressure
Study 20530299 — Surrogate Endpoint (SUR): Blood pressure
Study 31888551 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 29889923 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 20689095 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26916611 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31153358 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25583168 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 25583168 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 25583168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25583168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25583168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8156653 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 21209123 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17033926 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 8179948 — Surrogate Endpoint (SUR): Blood pressure
Study 3282825 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 20470802 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18768401 — Surrogate Endpoint (SUR): Blood pressure
Study 7588670 — Surrogate Endpoint (SUR): Serum creatinine
Study 28291238 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study 17324742 — Surrogate Endpoint (SUR): Blood pressure
Study 11277274 — Surrogate Endpoint (SUR): Bone mineral density
Study 2536765 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 15588321 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 9338554 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27249416 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 16813838 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 10421233 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31478892 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 21627339 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 25282112 — Monitoring Biomarker (MOI): Cell-free DNA
Study 2857061 — Surrogate Endpoint (SUR): Blood pressure
Study 375722 — Surrogate Endpoint (SUR): Blood pressure
Study 30058184 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 17178976 — Surrogate Endpoint (SUR): Blood pressure
Study 12410855 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12410855 — Surrogate Endpoint (SUR): Blood pressure
Study 6382999 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30395812 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 30395812 — Predictive Biomarker (PRD): IL13RA1 mRNA
Genes: IL13RA1; IL13R; IL13RA
Study 30395812 — Predictive Biomarker (PRD): IL13RA2 mRNA
Genes: IL13RA2; IL13R
Study 26078286 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18162241 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 14999536 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 14999536 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 14999536 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31921879 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 24913169 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 10442493 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7874586 — Surrogate Endpoint (SUR): Bone mineral density
Study 17386196 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 24918371 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24918371 — Surrogate Endpoint (SUR): Blood pressure
Study 21820142 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21820142 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16250037 — Safety Biomarker (SAF): Interleukin 12
Study 16250037 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 16250037 — Monitoring Biomarker (MOI): HBV DNA
Study 30541093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21054829 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 17541328 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17541328 — Surrogate Endpoint (SUR): Blood pressure
Study 17541328 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 16508926 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16508926 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29465679 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18089478 — Surrogate Endpoint (SUR): Blood pressure
Study 10338459 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10338459 — Surrogate Endpoint (SUR): Blood pressure
Study 7489145 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 1658183 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25412338 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 16221103 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 18681815 — Surrogate Endpoint (SUR): Blood pressure
Study 9008978 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23627924 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30506144 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 30506144 — Surrogate Endpoint (SUR): Serum calcium
Study 1390171 — Surrogate Endpoint (SUR): Serum calcium
Study 17535291 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17535291 — Surrogate Endpoint (SUR): Blood pressure
Study 15664680 — Surrogate Endpoint (SUR): Bone mineral density
Study 12127431 — Monitoring Biomarker (MOI): HBV DNA
Study 7786592 — Surrogate Endpoint (SUR): Pathological complete response
Study 28733999 — Predictive Biomarker (PRD): RTCA mRNA
Genes: RTCA; RPC; RPC1; RTC1; RTCD1
Study 26001561 — Surrogate Endpoint (SUR): Bone mineral density
Study 24113041 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 24113041 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 24113041 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24113041 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17873142 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28280973 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 16714251 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 11725694 — Surrogate Endpoint (SUR): Serum testosterone
Study 22092730 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 15332212 — Surrogate Endpoint (SUR): Serum creatinine
Study 27236001 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24916058 — Surrogate Endpoint (SUR): Blood pressure
Study 18030175 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 18030175 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 18030175 — Predictive Biomarker (PRD): Hormone receptor
Study 16161915 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 16161915 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 7937232 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 20929120 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 20929120 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 18979718 — Surrogate Endpoint (SUR): Blood pressure
Study 18979718 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12966321 — Surrogate Endpoint (SUR): Blood pressure
Study 8638838 — Surrogate Endpoint (SUR): Blood pressure
Study 1282218 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH